6699 — Angelalign Technology Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for Angelalign Technology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	fx Final	fx Final	Final	Final	Final
Net Income/Starting Line	51.5	37.4	8.58	11.7	—
Depreciation
Amortisation
Non-Cash Items	1.73	-6.02	1.23	-3.69	—
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	9.19	-19.3	0.362	-6.72	78.6
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	68.5	21.8	22.3	16.9	78.6
Capital Expenditures	-31	-14.2	-15.7	-28.3	-28.2
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	2.75	-9.57	-123	-111	-128
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-28.2	-23.7	-139	-139	-156
Financing Cash Flow Items	-20.5	-0.249	-1.15	-1.41	-1.97
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	391	-28.8	-26.3	-28.5	-26.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	426	3.33	-141	-153	-100